Red Queen Bio
red-queen-bioorganizationPath: /knowledge-base/organizations/red-queen-bio/
E556Entity ID (EID)
Page Recorddatabase.json — merged from MDX frontmatter + Entity YAML + computed metrics at build time
{
"id": "red-queen-bio",
"numericId": null,
"path": "/knowledge-base/organizations/red-queen-bio/",
"filePath": "knowledge-base/organizations/red-queen-bio.mdx",
"title": "Red Queen Bio",
"quality": 55,
"readerImportance": 35,
"researchImportance": 43.5,
"tacticalValue": null,
"contentFormat": "article",
"tractability": null,
"neglectedness": null,
"uncertainty": null,
"causalLevel": null,
"lastUpdated": "2026-03-13",
"dateCreated": "2026-02-15",
"llmSummary": null,
"description": "An AI biosecurity Public Benefit Corporation founded in 2025 by Nikolai Eroshenko and Hannu Rajaniemi (co-founders of HelixNano), spun out to build defensive biological countermeasures at the pace of frontier AI development. Raised a \\$15M seed round led by OpenAI based on a 'defensive co-scaling' thesis that couples defensive biological infrastructure to the same forces driving AI capability advancement.",
"ratings": {
"novelty": 8,
"rigor": 4,
"actionability": 6,
"completeness": 5
},
"category": "organizations",
"subcategory": "biosecurity-orgs",
"clusters": [
"biorisks",
"ai-safety",
"governance"
],
"metrics": {
"wordCount": 1493,
"tableCount": 4,
"diagramCount": 0,
"internalLinks": 5,
"externalLinks": 0,
"footnoteCount": 0,
"bulletRatio": 0.09,
"sectionCount": 19,
"hasOverview": true,
"structuralScore": 11
},
"suggestedQuality": 73,
"updateFrequency": 45,
"evergreen": true,
"wordCount": 1493,
"unconvertedLinks": [],
"unconvertedLinkCount": 0,
"convertedLinkCount": 0,
"backlinkCount": 3,
"citationHealth": {
"total": 16,
"withQuotes": 8,
"verified": 8,
"accuracyChecked": 8,
"accurate": 5,
"inaccurate": 1,
"avgScore": 0.9937499985098839
},
"hallucinationRisk": {
"level": "high",
"score": 80,
"factors": [
"biographical-claims",
"no-citations",
"few-external-sources"
]
},
"entityType": "organization",
"redundancy": {
"maxSimilarity": 12,
"similarPages": [
{
"id": "ea-biosecurity-scope",
"title": "Is EA Biosecurity Work Limited to Restricting LLM Biological Use?",
"path": "/knowledge-base/responses/ea-biosecurity-scope/",
"similarity": 12
},
{
"id": "bridgewater-aia-labs",
"title": "Bridgewater AIA Labs",
"path": "/knowledge-base/organizations/bridgewater-aia-labs/",
"similarity": 11
},
{
"id": "centre-for-long-term-resilience",
"title": "Centre for Long-Term Resilience",
"path": "/knowledge-base/organizations/centre-for-long-term-resilience/",
"similarity": 11
},
{
"id": "chan-zuckerberg-initiative",
"title": "Chan Zuckerberg Initiative",
"path": "/knowledge-base/organizations/chan-zuckerberg-initiative/",
"similarity": 11
},
{
"id": "metr",
"title": "METR",
"path": "/knowledge-base/organizations/metr/",
"similarity": 11
}
]
},
"coverage": {
"passing": 3,
"total": 13,
"targets": {
"tables": 6,
"diagrams": 1,
"internalLinks": 12,
"externalLinks": 7,
"footnotes": 4,
"references": 4
},
"actuals": {
"tables": 4,
"diagrams": 0,
"internalLinks": 5,
"externalLinks": 0,
"footnotes": 0,
"references": 2,
"quotesWithQuotes": 8,
"quotesTotal": 16,
"accuracyChecked": 8,
"accuracyTotal": 16
},
"items": {
"llmSummary": "red",
"schedule": "green",
"entity": "green",
"editHistory": "red",
"overview": "green",
"tables": "amber",
"diagrams": "red",
"internalLinks": "amber",
"externalLinks": "red",
"footnotes": "red",
"references": "amber",
"quotes": "amber",
"accuracy": "amber"
},
"ratingsString": "N:8 R:4 A:6 C:5"
},
"readerRank": 415,
"researchRank": 317,
"recommendedScore": 149.03
}External Links
No external links
Backlinks (3)
| id | title | type | relationship |
|---|---|---|---|
| biosecurity-orgs-overview | Biosecurity Organizations (Overview) | concept | — |
| biosecurity-overview | Biosecurity Interventions (Overview) | concept | — |
| ea-biosecurity-scope | Is EA Biosecurity Work Limited to Restricting LLM Biological Use? | analysis | — |